Amer Al Taie (Amer Al-Taie)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 7

Top Topics

Clinical Practice

Silver Nanoparticles

Top Venues

Infectious diseases and therapy

PharmacoEconomics

Antimicrobial stewardship & healthcare epidemiology : ASHE

This page only lists publications with an associated author ORCID identifier.

Publications

Jason Gordon, Maria Gheorghe, Simon D Goldenberg, Ryan Miller, James Dennis, Amer Al Taie
Capturing Value Attributes in the Economic Evaluation of Ceftazidime with Avibactam for Treating Severe Aerobic Gram-Negative Bacterial Infections in the United Kingdom. PharmacoEconomics (2023)
Jason Gordon, Maria Gheorghe, Cale Harrison, Ryan Miller, James Dennis, Lotte Steuten, Simon Goldenberg, Sumanth Gandra, Amer Al Taie
Estimating the Treatment and Prophylactic Economic Value of New Antimicrobials in Managing Antibiotic Resistance and Serious Infections for Common Pathogens in the USA: A Population Modelling Study. PharmacoEconomics (2023)
Myrto Barmpouni, Jason P Gordon, Ryan L Miller, James W Dennis, Vassilis Grammelis, Aris Rousakis, Kyriakos Souliotis, Garyphallia Poulakou, George L Daikos, Amer Al Taie
Clinical and Economic Value of Reducing Antimicrobial Resistance in the Management of Hospital-Acquired Infections with Limited Treatment Options in Greece. Infectious diseases and therapy (2023)
Thitima Kongnakorn, Eszter Tichy, Kirati Kengkla, Nuttawan Kanokwanvimol, Pichaya Suthipinijtham, Chanyapat Phuripakathorn, Amer Al Taie
Economic burden of antimicrobial resistance and inappropriate empiric treatment in Thailand. Antimicrobial stewardship & healthcare epidemiology : ASHE 3 (1) (2023)
Myrto Barmpouni, Jason P Gordon, Ryan L Miller, Clive R J Pritchard, James W Dennis, Vassilis Grammelis, Aris Rousakis, Kyriakos Souliotis, Garyphallia Poulakou, George L Daikos, Amer Al Taie
Estimating the Clinical and Economic Impact of Introducing a New Antibacterial into Greek Clinical Practice for the Management of Hospital-Acquired Infections with Limited Treatment Options. Infectious diseases and therapy (2022)
Myrto Barmpouni, Jason P Gordon, Ryan L Miller, Clive R J Pritchard, James W Dennis, Vassilis Grammelis, Aris Rousakis, Kyriakos Souliotis, Garyphallia Poulakou, George L Daikos, Amer Al Taie
Estimating the Clinical and Economic Impact of Introducing a New Antibacterial into Greek Clinical Practice for the Management of Hospital-Acquired Infections with Limited Treatment Options. Infectious diseases and therapy 12 (2) (2022)
Myrto Barmpouni, Jason P Gordon, Ryan L Miller, Clive R J Pritchard, James W Dennis, Vassilis Grammelis, Aris Rousakis, Kyriakos Souliotis, Garyphallia Poulakou, George L Daikos, Amer Al Taie
Estimating the Clinical and Economic Impact of Introducing a New Antibacterial into Greek Clinical Practice for the Management of Hospital-Acquired Infections with Limited Treatment Options. Infectious diseases and therapy (2022)